Author details

Full Name

Zhichao Liu

Affiliation

ORCID

Career Start Year

2010

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37061083	Artificial intelligence and real-world data for drug and food safety - A regulatory science perspective.	Regul Toxicol Pharmacol	2023
36355399	Exploring the Knowledge Gaps in Infant Drug Exposure From Human Milk: A Clinical Pharmacology Perspective.	Journal of Clinical Pharmacology	2023
37932302	A generative adversarial network model alternative to animal studies for clinical pathology assessment.	Nat Commun	2023
37714406	DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling.	Drug Discov Today	2023
37633327	DeepAmes: A deep learning-powered Ames test predictive model with potential for regulatory application.	Regul Toxicol Pharmacol	2023
37200521	TransOrGAN: An Artificial Intelligence Mapping of Rat Transcriptomic Profiles between Organs, Ages, and Sexes.	Chem Res Toxicol	2023
37317500	Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol.		2023
35241127	Towards accurate and reliable resolution of structural variants for clinical diagnosis.	Genome Biol	2022
35848999	Best practice and reproducible science are required to advance artificial intelligence in real-world applications.	Brief Bioinform	2022
36034596	Accurate species identification of food-contaminating beetles with quality-improved elytral images and deep learning.	Front Artif Intell	2022
36127716	Author Correction: Towards accurate and reliable resolution of structural variants for clinical diagnosis.	Genome Biol	2022
35479329	Editorial: Emerging Technologies Powering Rare and Neglected Disease Diagnosis and Theraphy Development.	Front Pharmacol	2022
36425225	Adaptability of AI for safety evaluation in regulatory science: A case study of drug-induced liver injury.	Front Artif Intell	2022
36518910	Corrigendum: DeepCarc: Deep learning-powered carcinogenicity prediction using model-level representation.	Front Artif Intell	2022
36561659	DeepCausality: A general AI-powered causal inference framework for free text: A case study of LiverTox.	Front Artif Intell	2022
34980216	Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.	Genome Biol	2022
34971401	Tox-GAN: An Artificial Intelligence Approach Alternative to Animal Studies-A Case Study With Toxicogenomics.	Toxicol Sci	2022
34939028	BERT-Based Natural Language Processing of Drug Labeling Documents: A Case Study for Classifying Drug-Induced Liver Injury Risk.	Front Artif Intell	2021
33967751	Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma.	Front Pharmacol	2021
33846644	Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology.	Nat Biotechnol	2021
33846381	Optimized imaging methods for species-level identification of food-contaminating beetles.	Sci Rep	2021
34216835	AI-based language models powering drug discovery and development.	Drug Discov Today	2021
33892143	Towards population-specific pharmacogenomics in the era of next-generation sequencing.	Drug Discov Today	2021
34136800	InferBERT: A Transformer-Based Causal Inference Framework for Enhancing Pharmacovigilance.	Front Artif Intell	2021
33863366	A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency.	Genome Biol	2021
33863344	Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions.	Genome Biol	2021
33356151	DeepDILI: Deep Learning-Powered Drug-Induced Liver Injury Prediction Using Model-Level Representation.	Chem Res Toxicol	2021
33078836	Identification of Translational microRNA Biomarker Candidates for Ketoconazole-Induced Liver Injury Using Next-Generation Sequencing.	Toxicol Sci	2021
33219404	Improving cardiotoxicity prediction in cancer treatment: integration of conventional circulating biomarkers and novel exploratory tools.	Archives of Toxicology	2021
34870186	DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation.	Front Artif Intell	2021
34409286	DICE: A Drug Indication Classification and Encyclopedia for AI-Based Indication Extraction.	Front Artif Intell	2021
34407882	X-CNV: genome-wide prediction of the pathogenicity of copy number variations.	Genome Med	2021
33113799	Linking Pharmacogenomic Information on Drug Safety and Efficacy with Ethnic Minority Populations.	Pharmaceutics	2020
31669330	Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity.	Drug Discov Today	2020
31707421	Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI).	ALTEX	2020
31808688	Can Transcriptomic Profiles from Cancer Cell Lines Be Used for Toxicity Assessment?	Chem Res Toxicol	2020
32032705	Study of pharmacogenomic information in FDA-approved drug labeling to facilitate application of precision medicine.	Drug Discov Today	2020
33101045	Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development.	Front Pharmacol	2020
32749457	A comprehensive rat transcriptome built from large scale RNA-seq-based annotation.	Nucleic Acids Res	2020
33235392	FDALabel for drug repurposing studies and beyond.	Nat Biotechnol	2020
32676024	Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach.	Front Pharmacol	2020
33330410	Deep Learning on High-Throughput Transcriptomics to Predict Drug-Induced Liver Injury.	Front Bioeng Biotechnol	2020
31338106	Five-Feature Model for Developing the Classifier for Synergistic vs. Antagonistic Drug Combinations Built by XGBoost.	Front Genet	2019
31623871	Toward Clinical Implementation of Next-Generation Sequencing-Based Genetic Testing in Rare Diseases: Where Are We?	Trends Genet	2019
30594306	Toxicogenomics: A 2020 Vision.	Trends Pharmacol Sci	2019
29902520	Drug-Induced Rhabdomyolysis Atlas (DIRA) for idiosyncratic adverse drug reaction management.	Drug Discov Today	2019
31092200	Correction to: Similarities and differences between variants called with human reference genome HG19 or HG38.	BMC Bioinformatics	2019
30871458	Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.	BMC Bioinformatics	2019
31445882	MicroRNAs hsa-miR-495-3p and hsa-miR-486-5p suppress basal and rifampicin-induced expression of human sulfotransferase 2A1 (SULT2A1) by facilitating mRNA degradation.	Biochem Pharmacol	2019
29695741	Comparing SVM and ANN based Machine Learning Methods for Species Identification of Food Contaminating Beetles.	Sci Rep	2018